FDA Approves Sutent for Pancreatic Cancer
Links shared publicly online about this topic.
- 271total visits
FDA Approves Sutent for Pancreatic Cancer
View full resource at onclive.com
Tags: Pancreatic Disease, Cancer, Bone Cancer, Ewing Family of Tumors, Pancreatic Cancer, FDA
Most Recently Shared on January 1, 2012 at 12:30 am By:
2011 Review: Two approvals in Pancreatic Cancer - Afinitor http://t.co/isMFgmSv and Sutent http://t.co/fgKGBbVU
FDA Approves Sutent For Rare Type Of Pancreatic Cancer
medicalnewstoday.com — “The U.S. Food and Drug Administration approved Sutent (sunitinib) to treat patients with progressive neuroendocrine cancerous tumors located in the pancreas that cannot be removed by surgery or th” View full resource at medicalnewstoday.com
Most Recently Shared on May 26, 2011 at 7:06 am By:
MNT Pancreatic Can Health News
FDA Approves Sutent For Rare Type Of Pancreatic Cancer http://mnt.to/3WmW #pancreaticcancer
Sutent Approved for Rare Pancreatic Cancer
health.yahoo.net — “MONDAY, May 23 (HealthDay News) -- U.S. Food and Drug Administration approval of Sutent (sunitinib) has been expanded to include people with neuroendocrine pancreatic cancer that is inoperable or has metastasized to other parts of the body.” View full resource at health.yahoo.net
Most Recently Shared on May 24, 2011 at 12:49 am By:
Jennifer Ann Grisso Active Health Library and Nurse
Sutent Approved for Rare Pancreatic Cancer: MONDAY, May 23 (HealthDay News) -- U.S. Food and Drug Administratio... http://bit.ly/jHoEuw
Sutent Approved for Rare Pancreatic Cancer - Drugs.com MedNews
drugs.com — “U.S. Food and Drug Administration approval of Sutent (sunitinib) has been expanded to include people with neuroendocrine pancreatic cancer that is inoperable or” View full resource at drugs.com
Most Recently Shared on May 23, 2011 at 10:54 pm By:
Sutent Approved for Rare Pancreatic Cancer - http://bit.ly/jtQdz9
Sutent Approved for Rare Pancreatic Cancer
health.yahoo.net — “MONDAY, May 23 (HealthDay News) -- U.S. Food and Drug Administration approval of Sutent (sunitinib) has been expanded to include people with neuroendocrine pancreatic cancer that is inoperable or has metastasized to other parts of the body.” View full resource at health.yahoo.net
Most Recently Shared on May 23, 2011 at 5:19 pm By:
allergydropz Doctor, Surgeon, ENT Doctor, and Physician
Yahoo health: Sutent Approved for Rare Pancreatic Cancer http://bit.ly/lrohqJ Full http://bit.ly/lP8e3J
Sutent Approved for Rare Pancreatic Cancer - Drugs.com MedNews
drugs.com — “U.S. Food and Drug Administration approval of Sutent (sunitinib) has been expanded to include people with neuroendocrine pancreatic cancer that is inoperable or” View full resource at drugs.com
Most Recently Shared on May 23, 2011 at 5:08 pm By:
Drugs and Devices OW OW Health
Sutent Approved for Rare Pancreatic Cancer: MONDAY, May 23 -- U.S. Food and Drug Administration approval o... http://bit.ly/jEXC4f #drug
Sutent Gains Indication for Advanced Pancreatic Tumors - ONA
oncologynurseadvisor.com — “The FDA has approved Sutent (sunitinib malate; Pfizer) for the treatment of progressive, well-differentiated pancreatic neuroendocrine tumors in patients with unresectable locally advanced or metastatic disease.” View full resource at oncologynurseadvisor.com
Most Recently Shared on May 23, 2011 at 2:50 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Sutent Gains Indication for Advanced Pancreatic Tumors http://goo.gl/fb/AhvBJ
Sutent Gains Indication for Advanced Pancreatic Tumors - MPR
empr.com — “The FDA has approved Sutent (sunitinib malate; Pfizer) for the treatment of progressive, well-differentiated pancreatic neuroendocrine tumors in patients with unresectable locally advanced or metastatic disease.” View full resource at empr.com
Most Recently Shared on May 23, 2011 at 2:35 pm By:
MPR News: Sutent Gains Indication for Advanced Pancreatic Tumors: The FDA has approved Sutent (sunitinib malate;... http://bit.ly/klWR8Y
SUTENT(R) Receives U.S. FDA Approval For Advanced Pancreatic Neuroendocrine Tumors
medicalnewstoday.com — “Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved SUTENT® (sunitinib malate) as the first anti-VEGF therapy to treat progressive, well-differentiated pa” View full resource at medicalnewstoday.com
Most Recently Shared on May 23, 2011 at 9:05 am By:
MNT Gastrointestinal Health News
SUTENT(R) Receives U.S. FDA Approval For Advanced Pancreatic Neuroendocrine Tumors http://mnt.to/3Wcr #gastrointestinal
FDA Approves Sutent For Rare Type Of Pancreatic Cancer
medicalnewstoday.com — “The U.S. Food and Drug Administration approved Sutent (sunitinib) to treat patients with progressive neuroendocrine cancerous tumors located in the pancreas that cannot be removed by surgery or th” View full resource at medicalnewstoday.com
Most Recently Shared on May 23, 2011 at 8:06 am By:
MNT Drug Approvals Health News
FDA Approves Sutent For Rare Type Of Pancreatic Cancer http://mnt.to/3Wc7 #regulatory
Sutent for Rare Type of Pancreatic Cancer Approved by FDA
disabled-world.com — “Sutent (sunitinib) approved for progressive neuroendocrine cancerous tumors located in the pancreas that cannot be removed by surgery or have spread to other parts of the body” View full resource at disabled-world.com
Most Recently Shared on May 22, 2011 at 9:21 pm By:
Disabled World Health Advocate and Health News
Sutent for Rare Type of Pancreatic Cancer Approved by FDA http://ff.im/-DWIfW
Stutent Approved For Advanced Pancreatic Neuroendocrine Tumors, USA
medicalnewstoday.com — “Sutent (sunitinib) has been approved by the FDA for treating advanced pancreatic neuroendocrine tumors. Specifically, the medication has been given the green light for patients whose tumors cannot” View full resource at medicalnewstoday.com
Most Recently Shared on May 21, 2011 at 9:32 pm By:
Endocrinology Wisdom OW Health
Stutent Approved For Advanced Pancreatic Neuroendocrine Tumors, USA: Sutent (sunitinib) has been approved by the... http://bit.ly/lqk0s6
FDA Approves Sutent for Rare Type of Pancreatic Cancer: SILVER SPRING, Md., May 20, 2011 /PRNewswire-USNewswire/... http://bit.ly/jR8gOy
medworm.com — “FDA Approves Sutent for Rare Type of Pancreatic Cancer: SILVER SPRING, Md., May 20, 2011 /PRNewswire-USNewswire/... http://bit.ly/jR8gOy” View full resource at medworm.com
Most Recently Shared on May 21, 2011 at 9:32 pm By:
Drugs and Devices OW OW Health
FDA Approves Sutent for Rare Type of Pancreatic Cancer: SILVER SPRING, Md., May 20, 2011 /PRNewswire-USNewswire/... http://bit.ly/jR8gOy
FDA Approves Sutent for Rare Type of Pancreatic Cancer
drugs.com — “Sutent (sunitinib) is used to treat pancreatic neuroendocrine tumors. Includes Sutent side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on May 21, 2011 at 8:13 am By:
Drugs and Devices OW OW Health
FDA Approves Sutent for Rare Type of Pancreatic Cancer: SILVER SPRING, Md., May 20, 2011 /PRNewswire-USNew... http://bit.ly/lGiA67 #drug
FDA Approves Sutent for Rare Type of Pancreatic Cancer
drugs.com — “Sutent (sunitinib) is used to treat pancreatic neuroendocrine tumors. Includes Sutent side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on May 21, 2011 at 7:16 am By:
FDA Approves Sutent for Rare Type of Pancreatic Cancer - http://bit.ly/j6v3Lp
Advertisement
